X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8968) 8968
Book Review (1651) 1651
Publication (504) 504
Book Chapter (78) 78
Conference Proceeding (36) 36
Dissertation (17) 17
Magazine Article (5) 5
Data Set (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6346) 6346
humans (5751) 5751
urothelial carcinoma (4786) 4786
male (3571) 3571
cancer (3370) 3370
female (3310) 3310
bladder cancer (3278) 3278
oncology (3085) 3085
aged (2958) 2958
middle aged (2825) 2825
urology & nephrology (2611) 2611
urinary bladder neoplasms - pathology (2566) 2566
prognosis (1810) 1810
tumors (1690) 1690
aged, 80 and over (1623) 1623
adult (1546) 1546
transitional-cell carcinoma (1498) 1498
carcinoma (1389) 1389
chemotherapy (1356) 1356
pathology (1342) 1342
urology (1277) 1277
bladder (1270) 1270
survival (1214) 1214
carcinoma, transitional cell - pathology (1120) 1120
analysis (1094) 1094
urothelial cancer (1083) 1083
immunohistochemistry (1017) 1017
metastasis (996) 996
care and treatment (988) 988
retrospective studies (965) 965
diagnosis (939) 939
recurrence (936) 936
neoplasm staging (932) 932
bladder-cancer (931) 931
urinary bladder neoplasms - genetics (928) 928
treatment outcome (926) 926
radical cystectomy (914) 914
expression (911) 911
urinary-bladder (911) 911
urinary bladder neoplasms - surgery (857) 857
research (842) 842
urothelium - pathology (805) 805
urinary bladder neoplasms - drug therapy (796) 796
cystectomy (781) 781
risk factors (765) 765
transitional-cell-carcinoma (754) 754
urinary bladder (736) 736
neoplasm invasiveness (726) 726
urinary bladder neoplasms - metabolism (703) 703
urinary bladder neoplasms - diagnosis (696) 696
medicine & public health (679) 679
surgery (673) 673
progression (658) 658
urinary bladder neoplasms - mortality (645) 645
animals (625) 625
carcinoma, transitional cell - surgery (596) 596
health aspects (573) 573
development and progression (549) 549
patients (548) 548
disease-free survival (529) 529
cisplatin (524) 524
urinary bladder neoplasms - therapy (524) 524
abridged index medicus (486) 486
immunotherapy (479) 479
urologic neoplasms - pathology (478) 478
follow-up studies (464) 464
genetic aspects (464) 464
cell biology (462) 462
disease progression (462) 462
gene expression (459) 459
risk (459) 459
upper urinary-tract (447) 447
biomarkers (446) 446
survival rate (442) 442
medical prognosis (435) 435
medicine (431) 431
kaplan-meier estimate (425) 425
antineoplastic combined chemotherapy protocols - therapeutic use (416) 416
carcinoma, transitional cell - mortality (414) 414
apoptosis (409) 409
therapy (395) 395
transitional cell carcinoma (395) 395
cell line, tumor (393) 393
urine (392) 392
renal pelvis (388) 388
survival analysis (388) 388
proteins (387) 387
cytology (383) 383
multivariate analysis (382) 382
carcinoma, transitional cell - drug therapy (381) 381
bacillus-calmette-guerin (368) 368
mortality (367) 367
medical research (364) 364
adenocarcinoma (363) 363
neoadjuvant chemotherapy (363) 363
ureter (358) 358
studies (354) 354
gene expression regulation, neoplastic (352) 352
patient outcomes (347) 347
invasiveness (346) 346
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8467) 8467
German (210) 210
French (201) 201
Spanish (87) 87
Japanese (43) 43
Russian (20) 20
Dutch (7) 7
Chinese (5) 5
Turkish (5) 5
Polish (4) 4
Croatian (2) 2
Korean (2) 2
Portuguese (2) 2
Czech (1) 1
Finnish (1) 1
Hungarian (1) 1
Italian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 544 - 548
Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | BLADDER-CANCER | THERAPY | LANDSCAPE | SUBTYPES | UROTHELIAL CARCINOMA | MULTIDISCIPLINARY SCIENCES | GENES | ADAPTIVE IMMUNE RESISTANCE | MPDL3280A | CD8-Positive T-Lymphocytes - cytology | Humans | Antibodies, Monoclonal - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Neoplasm Metastasis | Urologic Neoplasms - drug therapy | Urologic Neoplasms - genetics | Immunotherapy | Antibodies - immunology | Antigens, Neoplasm - metabolism | Transforming Growth Factor beta - antagonists & inhibitors | Antigens, Neoplasm - analysis | Disease Models, Animal | Fibroblasts - metabolism | Antibodies - therapeutic use | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacology | Treatment Outcome | B7-H1 Antigen - immunology | Urologic Neoplasms - immunology | Antibodies - pharmacology | Tumor Microenvironment - immunology | Collagen - metabolism | Phenotype | Animals | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | CD8-Positive T-Lymphocytes - drug effects | Urothelium - immunology | Mice | Mutation | CD8-Positive T-Lymphocytes - immunology | Urothelium - drug effects | Transforming Growth Factor beta - metabolism | Cohort Studies | Drug Resistance, Neoplasm - drug effects | PD-1 protein | CD8 antigen | Transforming growth factor-a | Antibodies | Parenchyma | Lymphocytes T | Metastasis | Immunity | Metastases | Genotype & phenotype | Signal transduction | Lymphocytes | Cell cycle | Fibroblasts | Growth factors | Urothelial cancer | Phenotypes | Cytokines | Melanoma | Blocking | Gene expression | Patients | Generalized linear models | Signaling | Stromal cells | Medical prognosis | Collagen | PD-L1 protein | Ligands | Determinants | Infiltration | Cancer | Tumors | Apoptosis | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 04/2009, Volume 33, Issue 4, pp. 556 - 567
Journal Article
Clinical Genitourinary Cancer, ISSN 1558-7673, 04/2019, Volume 17, Issue 2, pp. 114 - 124
There are no previous reports directly evaluating immunologic conditions in tumor microenvironment including both bladder cancer (BCa) and upper urinary tract... 
Heterogeneity | Immune checkpoint | Prognosis | Urothelial carcinoma | Tumor tissue-infiltrating lymphocytes | SURVIVAL | MULTICENTER | METASTATIC UROTHELIAL CARCINOMA | SINGLE-ARM | CHEMOTHERAPY | CISPLATIN | ONCOLOGY | UROLOGY & NEPHROLOGY | EXPRESSION | ASSOCIATION | Research | Lymphocytes | Immunity | Urinary tract cancer
Journal Article
JAMA, ISSN 0098-7484, 05/2018, Volume 319, Issue 18, pp. 1880 - 1888
Journal Article
MODERN PATHOLOGY, ISSN 0893-3952, 01/2018, Volume 31, Issue S1, pp. S80 - S95
Journal Article
BULLETIN DU CANCER, ISSN 0007-4551, 02/2017, Volume 104, Issue 2, pp. 195 - 201
Urothelial tumors are very rare in children (to date, only about 150 cases have been reported worlwide). Only 20% occur before the age of ten. The aim of this... 
YOUNG-ADULTS | Hematuria | UPPER URINARY-TRACT | NEOPLASMS | Bladder | Urothelial tumors | CANCER | ONCOLOGY | TRANSITIONAL-CELL CARCINOMA | COSTELLO-SYNDROME | PEDIATRIC-PATIENTS | AGGRESSIVE BLADDER-CARCINOMA | TERM-FOLLOW-UP | PATIENT | Children
Journal Article
European Urology, ISSN 0302-2838, 2011, Volume 60, Issue 6, pp. 1258 - 1265
Journal Article
Medicine, ISSN 0025-7974, 01/2019, Volume 98, Issue 2, pp. e14091 - e14091
Journal Article